Autolus Therapeutics AUTL
NASDAQ AUTL
$1.78 -0.07 (-3.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Autolus Therapeutics (AUTL) Return on Invested Capital [ROIC] (2018 - 2019)

Updated

Autolus Therapeutics' Return on Invested Capital [ROIC] was -36.06% in FY2019.

Analysis

Autolus Therapeutics (AUTL) Return on Invested Capital [ROIC] (2018 - 2019) Analysis & Trends

  • Per Business Quant data, Return on Invested Capital [ROIC] in earlier years was -9.09% in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Autolus Therapeutics 631.98 Mn -692.11 Mn 25.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -29.37%
Dec 31, 2018 -8.45%
API Access

Autolus Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=AUTL&period=max&api_key=YOUR_API_KEY